Functional Polymorphisms in the Cyclooxygenase 2 (COX-2) Gene and Risk of Breast Cancer in a Chinese Population

REFERENCES

• Ali , I. U. , Luke , B. T. , Dean , M. and Greenwald , P. 2005 . Allellic variants in regulatory regions of cyclooxygenase-2: Association with advanced colorectal adenoma . Br. J. Cancer , 93 : 953 – 959 .
   PubMedGoogle Scholar
• Campa , D. , Zienolddiny , S. , Maggini , V. , Skaug , V. , Haugen , A. and Canzian , F. 2004 . Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer . Carcinogenesis , 25 : 229 – 235 .
   PubMed Web of Science ®Google Scholar
• Cao , Y. and Prescott , S. M. 2002 . Many actions of cyclooxygenase-2 in cellular dynamics and in cancer . J. Cell. Physiol. , 190 : 279 – 286 .
   PubMed Web of Science ®Google Scholar
• Chan , G. , Boyle , J. O. , Yang , E. K. , Zhang , F. , Sacks , P. G. , Shah , J. P. , Edelstein , D. , Soslow , R. A. , Koki , A. T. , Woerner , B. M. , Masferrer , J. L. and Dannenberg , A. J. 1999 . Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck . Cancer Res. , 59 : 991 – 994 .
   PubMed Web of Science ®Google Scholar
• Coffey , R. J. , Hawkey , C. J. , Damstrup , L. , Graves-Deal , R. , Daniel , V. C. , Dempsey , P. J. , Chinery , R. , Kirkland , S. C. , DuBois , R. N. , Jetton , T. L. and Morrow , J. D. 1997 . Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins and mitogenesis in polarizing colon cancer cells . Proc. Natl. Acad. Sci. USA , 94 : 657 – 662 .
   PubMed Web of Science ®Google Scholar
• Cok , S. J. and Morrison , A. R. 2001 . The 3V-untranslated region of murine cyclooxygenase-2 containsmultiple regulatory elements that alter message stability and translational efficiency . J. Biol. Chem. , 276 : 23179 – 23185 .
   PubMed Web of Science ®Google Scholar
• Cox , D. G. , Pontes , C. , Guino , E. , Navarro , M. , Osorio , A. , Canzian , F. , Moreno , V. and Bellvitge Colorectal Cancer Study Group . 2004 . Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer . Br. J. Cancer , 91 : 339 – 343 .
   PubMed Web of Science ®Google Scholar
• Denkert , C. , Winzer , K. J. and Hauptmann , S. 2004 . Prognostic impact of cyclooxygenase-2 in breast cancer . Clin. Breast Cancer , 4 : 428 – 433 .
   PubMedGoogle Scholar
• Dixon , D. A. 2003 . Regulation of COX-2 expression in human cancers . Prog. Exp. Tumor Res. , 37 : 52 – 71 .
   PubMedGoogle Scholar
• DuBois , R. N. , Awad , J. , Morrow , J. , Roberts , L. J. 2nd and Bishop , P. R. 1994 . Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester . J. Clin. Invest. , 93 : 493 – 498 .
   PubMed Web of Science ®Google Scholar
• Eberhart , C. E. , Coffey , R. J. , Radhika , A. , Giardiello , F. M. , Ferrenbach , S. and DuBois , R. N. 1994 . Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas . Gastroenterology , 107 : 1183 – 1188 .
   PubMed Web of Science ®Google Scholar
• Fujita , H. , Koshida , K. , Keller , E. T. , Takahashi , Y. , Yoshimito , T. , Namiki , M. and Mizokami , A. 2002 . Cyclooxygenase-2 promotes prostate cancer progression . Prostate , 53 : 232 – 240 .
   PubMed Web of Science ®Google Scholar
• Gasparini , G. , Longo , R. , Sarmiento , R. and Morabito , A. 2003 . Inhibitors of cyclooxygenase 2: A new class of anticancer agents? . Lancet Oncol. , 4 : 605 – 615 .
   PubMed Web of Science ®Google Scholar
• Half , E. , Tang , X. M. , Gwyn , K. , Sahin , A. , Wathen , K. and Sinicrope , F. A. 2002 . Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ . Cancer Res. , 62 : 1676 – 1681 .
   PubMed Web of Science ®Google Scholar
• Harris , R. E. , Chlebowski , R. T. , Jackson , R. D. , Frid , D. J. , Ascenseo , J. L. , Anderson , G. , Loar , A. , Rodabough , R. J. , White , E. , McTiernan , A. and Women's Health Initiative . 2003 . Breast cancer and nonsteroidal anti-inflammatory drugs: Prospective results from the Women's Health Initiative . Cancer Res. , 63 : 6096 – 6101 .
   PubMed Web of Science ®Google Scholar
• Hu , Z. , Miao , X. , Ma , H. , Wang , X. , Tan , W. , Wei , Q. , Lin , D. and Shen , H. 2005 . A common polymorphism in the 3_UTR of cyclooxygenase 2/prostaglandin synthase 2 gene and risk of lung cancer in a Chinese population . Lung Cancer , 48 : 11 – 17 .
   PubMedGoogle Scholar
• Hwang , D. , Scollard , D. , Byrne , J. and Levine , E. 1998 . Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer . JNCI , 90 : 455 – 460 .
   PubMed Web of Science ®Google Scholar
• Kang , S. , Kim , Y. B. , Kim , M. H. , Yoon , K. S. , Kim , J. W. , Park , N. H. , Song , Y. S. , Kang , D. , Yoo , K. Y. , Kang , S. B. and Lee , H. P. 2005 . Polymorphism in the nuclear factor kappa-B binding promoter region of cyclooxygenase-2 is associated with an increased risk of bladder cancer . Cancer Lett. , 217 : 11 – 16 .
   PubMed Web of Science ®Google Scholar
• Koh , W. P. , Yuan , J. M. , van den Berg , D. , Lee , H. P. and Yu , M. C. 2004 . Interaction between cyclooxygenase-2 gene polymorphism and dietary n-6 polyunsaturated fatty acids on colon cancer risk: The Singapore Chinese Health Study . Br. J. Cancer , 90 : 1760 – 1764 .
   PubMedGoogle Scholar
• Koki , A. , Khan , N. K. , Woerner , B. M. , Dannenberg , A. J. , Olson , L. , Seibert , K. , Edwards , D. , Hardy , M. , Isakson , P. and Masferrer , J. L. 2002 . Cyclooxygenase-2 in human pathological disease . Adv. Exp. Med. Biol. , 507 : 177 – 184 .
   PubMed Web of Science ®Google Scholar
• Konheim , Y. L. and Wolford , J. K. 2003 . Association of a promoter variant in the inducible cyclooxygenase-2 gene (PTGS2) with type 2 diabetes mellitus in Pima Indians . Hum. Genet. , 113 : 377 – 381 .
   PubMedGoogle Scholar
• Kuersten , S. and Goodwin , E. B. 2003 . The power of the 3′ UTR: Translational control and development . Nat. Rev. Genet. , 4 : 626 – 637 .
   PubMed Web of Science ®Google Scholar
• Langsenlehner , U. , Yazdani-Biuki , B. , Eder , T. , Renner , W. , Wascher , T. C. , Paulweber , B. , Weitzer , W. , Samonigg , H. and Krippl , P. 2006 . The cyclooxygenase-2 (PTGS2) 8473T > C polymorphism is associated with breast cancer risk . Clin. Cancer Res. , 12 : 1392 – 1394 .
   PubMedGoogle Scholar
• Liu , C. H. , Chang , S. , Narko , K. , Trifan , O. C. , Wu , M. , Smith , E. , Haudenschild , C. , Lane , T. F. and Hla , T. 2001 . Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice . J. Biol. Chem. , 276 : 18563 – 18569 .
   PubMed Web of Science ®Google Scholar
• Marks , F. and Furstenberger , G. 2000 . Cancer chemoprevention through interruption of multistage carcinogenesis. The lessons learnt by comparing mouse skin carcinogenesis and human large bowel cancer . Eur. J. Cancer , 36 : 314 – 329 .
   PubMed Web of Science ®Google Scholar
• Mestre , J. R. , Rivadeneira , D. E. , Mackrell , P. J. , Duff , M. , Stapleton , P. P. , Mack-Strong , V. , Maddali , S. , Smyth , G. P. , Tanabe , T. and Daly , J. M. 2001 . Overlapping CRE and E-box promoter elements can independently regulate COX-2 gene transcription in macrophages . FEBS Lett. , 496 : 147 – 151 .
   PubMedGoogle Scholar
• Panguluri , R. C. , Long , L. O. , Chen , W. , Wang , S. , Coulibaly , A. , Ukoli , F. , Jackson , A. , Weinrich , S. , Ahaghotu , C. , Isaacs , W. and Kittles , R. A. 2004 . COX-2 gene promoter haplotypes and prostate cancer risk . Carcinogenesis , 25 : 961 – 966 .
   PubMedGoogle Scholar
• Papafili , A. , Hill , M. R. , Brull , D. J. , McAnulty , R. J. , Marshall , R. P. , Humphries , S. E. and Laurent , G. J. 2002 . Common promoter variant in cyclooxygenase-2 represses gene expression: Evidence of role in acute-phase inflammatory response . Arterioscler Thromb. Vasc. Biol. , 22 : 1631 – 1636 .
   PubMed Web of Science ®Google Scholar
• Park , J. M. , Choi , J. E. , Chae , M. H. , Lee , W. K. , Cha , S. I. , Son , J. W. , Kim , C. H. , Kam , S. , Kang , Y. M. , Jung , T. H. and Park , J. Y. 2006 . Relationship between cyclooxygenase 8473T > C polymorphism and risk of lung cancer: A case-control study . BMC Cancer , 6 : 70 – 70 .
   PubMedGoogle Scholar
• Romano , M. and Claria , J. 2003 . Cyclooxygenase-2 and 5-lipoxygenase converging functions on cell proliferation and tumor angiogenesis: Implications for cancer therapy . FASEB J. , 17 : 1986 – 1995 .
   PubMed Web of Science ®Google Scholar
• Sakoda , L. C. , Gao , Y. T. , Chen , B. E. , Chen , J. , Rosenberg , P. S. , Rashid , A. , Deng , J. , Shen , M. C. , Wang , B. S. , Han , T. Q. , Zhang , B. H. , Cohen-Webb , H. , Yeager , M. , Welch , R. , Chanock , S. , Fraumeni , J. F. Jr. and Hsing , A. W. 2005 . Prostaglandin-endoperoxide synthase 2 (PTGS2) gene polymorphisms and risk of biliary tract cancer and gallstones: A population-based study in Shanghai, China . Carcinogenesis , Dec 16 [Epub ahead of print]
   PubMedGoogle Scholar
• Sharp , C. R. , Collet , J. P. , McNutt , M. , Belzile , E. , Boivin , J. F. and Hanley , J. A. 2000 . Nested case control study of the effect of non-steroidal anti-inflammatory drugs on breast cancer risk and stage . Br. J. Cancer , 83 : 112 – 120 .
   PubMedGoogle Scholar
• Sheng , H. , Shao , J. , Dixon , D. A. , Williams , C. S. , Prescott , S. M. , DuBois , R. N. and Beauchamp , R. D. 2000 . Transforming growth factor-beta1 enhances Ha-ras-induced expression of cyclooxygenase-2 in intestinal epithelial cells via stabilization of mRNA . J. Biol. Chem. , 275 : 6628 – 6635 .
   PubMed Web of Science ®Google Scholar
• Siezen , C. L. , van Leeuwen , A. I. , Kram , N. R. , Luken , M. E. , van Kranen , H. J. and Kampman , E. 2005 . Colorectal adenoma risk is modified by the interplay between polymorphisms in arachidonic acid pathway genes and fish consumption . Carcinogenesis , 26 : 449 – 457 .
   PubMed Web of Science ®Google Scholar
• Singh , B. and Lucci , A. 2002 . Role of cyclooxygenase-2 in breast cancer . J. Surg. Res. , 108 : 173 – 179 .
   PubMed Web of Science ®Google Scholar
• Smith , W. L. , Garavito , R. M. and DeWitt , D. L. 1996 . Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2 . J. Biol. Chem. , 271 : 33157 – 33160 .
   PubMed Web of Science ®Google Scholar
• Szczeklik , W. , Sanak , M. and Szczeklik , A. 2004 . Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma . J. Allergy Clin. Immunol. , 114 : 248 – 253 .
   PubMed Web of Science ®Google Scholar
• Tanabe , T. and Tohnai , N. 2002 . Cyclooxygenase isozymes and their gene structures and expression . Prostaglandins Other Lipid Mediat. , 68–69 : 95 – 114 .
   PubMed Web of Science ®Google Scholar
• Terry , M. B. , Gammon , M. D. , Zhang , F. F. , Tawfik , H. , Teitelbaum , S. L. , Britton , J. A. , Subbaramaiah , K. , Dannenberg , A. J. and Neugut , A. I. 2004 . Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk . J. Am. Med. Assoc. , 291 : 2433 – 2440 .
   PubMed Web of Science ®Google Scholar
• Tsujii , M. , Kawano , S. , Tsuji , S. , Sawaoka , H. , Hori , M. and DuBois , R. N. 1998 . Cyclooxygenase regulates angiogenesis induced by colon cancer cells . Cell , 93 : 705 – 716 .
   PubMed Web of Science ®Google Scholar
• Ulrich , C. M. , Whitton , J. , Yu , J. H. , Sibert , J. , Sparks , R. , Potter , J. D. and Bigler , J. 2005 . PTGS2 (COX-2) −765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs . Cancer Epidemiol. Biomarkers Prev. , 14 : 616 – 619 .
   PubMedGoogle Scholar
• Wolff , H. , Saukkonen , K. , Anttila , S. , Karjalainen , A. , Vainio , H. and Ristimaki , A. 1998 . Expression of cyclooxygenase-2 in human lung carcinoma . Cancer Res. , 58 : 4997S – 5001S .
   PubMed Web of Science ®Google Scholar
• Zhang , X. , Miao , X. , Tan , W. , Ning , B. , Liu , Z. , Hong , Y. , Song , W. , Guo , Y. , Zhang , X. , Shen , Y. , Qiang , B. , Kadlubar , F. F. and Lin , D. 2005 . Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer . Gastroenterology , 129 : 565 – 576 .
   PubMed Web of Science ®Google Scholar